The smallest pixels yet created – a million times smaller than those in smartphones, made by trapping particles of light under tiny rocks of gold – could be used for new types of large-scale flexible displays, big enough to cover entire buildings.
Rates of PTSD in the police service revealed as close to five times higher than in the UK population. Cambridge researchers and a policing charity are calling for “national mental health strategy” in UK law enforcement.
An international group of scientists led by the University of Cambridge has finished designing the ‘brain’ of the Square Kilometre Array (SKA), the world’s largest radio telescope. When complete, the SKA will enable astronomers to monitor the sky in unprecedented detail and survey the entire sky much faster than any system currently in existence.
New study of FOI documents uncovers provisions that could allow the beverage giant to suppress findings from health science it funds at North American universities. Researchers argue that Coca-Cola’s contracts run counter to their public declarations of openness.
A new type of money that allows users to make decisions based on information arriving at different locations and times, and that could also protect against attacks from quantum computers, has been proposed by a researcher at the University of Cambridge.
Researchers have developed a method that could drastically accelerate the search for new drugs to treat mental health disorders such as schizophrenia.
Cambridge researchers launch charity to tackle ‘slow motion spinal cord injury’ affecting up to a million UK adults07 May 2019
Today sees the official launch of Myelopathy.org, a charity dedicated to one of the most common, yet under-diagnosed neurological conditions. The charity is the brainchild of Dr Mark Kotter, neurosurgeon and clinician scientist at the University of Cambridge, who works on a disorder known officially as Degenerative Cervical Myelopathy.
Scientists at the University of Cambridge have developed a new test that can reliably predict the future course of inflammatory bowel disease in individuals, transforming treatments for patients and paving the way for a personalised approach.